Review: Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?
Open Access
- 1 August 2008
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Cardiovascular Disease
- Vol. 2 (4), 249-259
- https://doi.org/10.1177/1753944708094227
Abstract
It is estimated that 10% of pregnancies are affected by hypertension worldwide. Approximately one-half of all hypertensive pregnancy disorders are due to preeclampsia, a pregnancy-specific disorder, its distinctive feature being either sudden onset, or worsening of pre-existing proteinuria. It has become increasingly recognized that women with a history of preeclampsia are at increased risk for future cardiovascular disease (CVD), but the mechanisms of this increase in risk are unclear. One possible explanation is that these two conditions share several common metabolic abnormalities as risk factors, including obesity, insulin resistance, and lipid abnormalities that may lead to preeclampsia and CVD at different times of a woman's life. Recent studies have revealed that, similar to CVD, several mediators of endothelial cell dysfunction are up-regulated in preeclampsia. Free radical derived oxidative stress, various inflammatory markers, including neutrophil response, C-reactive protein, and leukocyte adhesion, may contribute to endothelial dysfunction in both preeclampsia and coronary atherosclerosis. Alternatively, preeclampsia itself may induce metabolic and vascular changes that may increase the overall future risk for CVD in affected women. Therefore, at present, it remains unclear whether preeclampsia is a formal risk factor for CVD, or identifies women at increased risk for CVD later in life. Pending large-scale studies aiming to examine the causality of this association, women with a history of preeclampsia should be counseled regarding their increased risks for hypertension and other cardiovascular sequelae later in life, followed closely and treated aggressively for modifiable CVD risk factors.Keywords
This publication has 83 references indexed in Scilit:
- Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysisBMJ, 2007
- Preeclampsia and the Risk of Ischemic Stroke Among Young WomenStroke, 2006
- Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With PreeclampsiaHypertension, 2004
- Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsiaInternational Journal of Gynecology & Obstetrics, 1996
- Homocysteine and coronary atherosclerosisJournal of the American College of Cardiology, 1996
- Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: Their significancesAmerican Journal of Obstetrics and Gynecology, 1996
- Clotting inhibitors and fibronectin as potential markers in preeclampsiaInternational Journal of Gynecology & Obstetrics, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Long term follow‐up of women with hypertension in pregnancyInternational Journal of Gynecology & Obstetrics, 1988
- Risk factors for myocardial infarction in young women.Journal of Epidemiology and Community Health, 1976